Next-generation 'epigenetic' cancer pill shown to be safe in phase I trial

Tuesday, May 1, 2012 - 10:30 in Health & Medicine

Scientists have shown that a brand new type of cancer pill that exploits the emerging field of epigenetics is safe for human use, according to Phase I trial results.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net